Ciprofibrate diminishes non-HDL-c and improves HDL-c in patients with frederickson type IV dyslipidemia phenotype

Documents similaires

• Ciprofibrate diminishes non-hdlc and improves hdlc in patients with frederickson type iv dyslipidemia phenotype
  par: M. Cabrera de B
  Publié: (2005)
• Clinical and immunological factors associated with lupus nephritis in patients from northwestern Colombia
  par: Adriana Pérez
  Publié: (2003)
• Distribución del polimorfismo G721A de ICAM-1 y niveles de séricos de HDLC y reactantes de fase aguda en pacientes mestizos mexicanos con osteoartritis
  par: F.A. Amador Amador
  Publié: (2007)
• Effect of n-3 polyunsaturated fatty acids on the lipidic profile of healthy Mexican volunteers
  par: Ofelia Angulo
  Publié: (1997)
• What are the current guidelines for treating hypertension and hyperlipidemia?
  par: Tripdatabase
  Publié: (2026)